We describe two retroviral vector-based recombination substrate systems designed to assay for lymphoid VDJ recombinase activity in cultured cells. Both substrates incorporate a constitutive dominant marker gene (the simian virus promoter-driven neo gene) to allow selection of cells that stably integrate the substrate. Both substrates also include a second marker gene that becomes transcriptionaHly active only when inverted by a site-specific recombination event between flanking immunoglobulin variable-region gene segments. The first vector, similar in structure to previous retrovirus-based recombination substrates, utilizes the bacterial guanine-xanthine phosphoribosyltransferase gene (gpt) as its activatable marker; detection of inversion (VDJ recombinase activity) involves drug selection and Southern blotting analyses. We have used this vector to make a more extensive and quantitative survey of VDJ recombinase activity in B-lineage cell lines than has previously been performed with stable substrates, and we have compared our results with those of other studies that use transient recombination substrates. In the second vector, the activatable gene is the bacterial 0-galactosidase gene (lacZ). Detection for inversional activation of this gene is achieved by a fluorogenic assay, termed FACS-Gal, that detects ,-galactosidase activity in viable cells. The latter assay has the unique advantage of rapidly detecting cells that undergo recombination and also allows viable sorting of cells on the basis of the presence or absence of VDJ recombinase activity. We have used the lacZ vector to rapidly quantitate VDJ recombinase activity in B-lineage cell lines and compared the results with those obtained with the gpt vector. We have also used the lacZ vector to isolate variant pre-B-cell lines with low and high levels of VDJ recombinase activity. 
The ability of the immune system to respond to an unlimited array of antigens depends on somatic assembly of genes encoding the antigen-binding receptors expressed by B and T cells (reviewed in references 12 and 20) . The approximately 100 N-terminal amino acids of the polypeptide chains that comprise the antigen receptors are termed variable regions because they vary among chains of the same class. Variable regions of complementary polypeptide chains combine to form the antigen-binding pocket of the receptor. During somatic lymphocyte development, the genes encoding these variable regions are assembled from component gene segments. A variable region gene is assembled from either two (V and J) or three (V, D, and J) germ line segments. The genetic locus used to encode the variable region of a given polypeptide chain usually has multiple copies of each of the V, D (if present), and J segments. Combinatorial assortment of these different segments, coupled with further diversity that can be created at the junctions of segments joined together, allows for the assembly of an almost infinite number of different variable-region genes. All germ line variable-region gene segments are flanked by recombination recognition sequences (or signal sequences) that mediate the joining event (7, 18) . Joining of two segments appears to initiate with recognition of the signal sequences and site-specific double-stranded breaks which separate the coding sequences from the signal sequences (1) . Subsequently and in discrete joining steps, the two coding regions are brought together imprecisely while the signal sequences are joined back-to-back. The relative orientation of the segments to be joined determines whether the join will delete or invert the sequences between the two joined segments (see below).
Although neither the enzymes involved in VDJ recombination nor the genes encoding these enzymes have yet been isolated, several strategies have been used to assay for VDJ recombinase activity. These strategies have involved introduction of exogenous DNA constructs (termed recombination substrates because they contain variable-region gene segments that act as substrates for the VDJ recombinase) into cell lines that have VDJ recombinase activity. Recombination substrates can either be permanently integrated into chromosomal DNA to yield stable cell lines bearing the substrates (3, 13) or be propagated extrachromosomally for transient assays (9) . Subsequently, the introduced DNA is analyzed to see whether it has undergone VDJ recombination. These assays have revealed that B and T cells express a common VDJ recombinase that can act on all classes of antigen receptor variable regions (21) and have suggested that the activity of the recombinase is targeted in a tissueand stage-specific manner to particular genetic loci, depending on the accessibility of the given locus (4, 21) . Limited surveys of stably introduced substrates, together with more extensive surveys using transiently introduced substrates, suggested that VDJ recombinase activity is limited to cell lines representing the early stages of the B, T, and macro-phage lineages (4, 5, 14, 19 (14) . Stable substrate studies allow for the analysis and manipulation of the chromatin structure of the substrate, can allow for long-term studies of substrate recombination after treatment of perturbation of the cells, and may allow detection (because of more powerful selection techniques) of lower levels of recombinase activity (4, 19, 21 
MATERIALS AND METHODS
Recombination substrate constructions and analysis of rearrangements by Southern blotting. Constructions were made into the pDOL retroviral vector, using restriction fragments (with modified ends) containing kappa light-chain V or J segments, the gpt gene, and the lacZ gene as described in the legends to Fig. 1 and 2 . Preparation of genomic DNA from cell lines containing the constructs, restriction enzyme digestion of genomic DNA, Southern blotting, preparation of radiolabeled probes, and hybridization were performed as previously described (21) . Diagnostic digestions and probes that distinguish between the rearranged and unrearranged forms of the recombination substrates on Southern blots are described in the legends to Fig.  1 (14) .
RESULTS
Recombination substrate design. A recombination substrate designated V-gpt-J-neo, similar to previous retrovirusbased substrates (5, 19) , was constructed within the pDOL retroviral vector and contained VK and JK segments as well as two drug-selectable marker genes (gpt and neo) (Fig. 1A) cells in MPA-containing medium, and these cells only appeared 3 to 4 weeks after exposure to MPA, suggesting that only very rare 70Z cells had rearranged the V-gpt-J-neo substrate.
The verify that MPA resistance in pre-B-cell lines resulted from conventional joining between the V and J segments, and to attempt to understand the differing responses of pre-B-cell lines to MPA treatment, genomic DNA was prepared from the cell lines 2 to 4 weeks after infection as well as after growth in MPA-containing medium. The DNA was subjected to Southern blot analysis, using restriction digests and a probe that conveniently distinguished between unrearranged and rearranged versions of the V-gpt-J-neo substrate (for details, see legend to Fig. 1B ). The substrate DNA in all samples from MPA-resistant populations had undergone conventional V-J joining (representative data shown in Fig. 1B ). However, analysis of samples before placement in MPA revealed different relative levels of the substrate in the unrearranged versus the rearranged form (Fig. 1B) . Notably, cell lines (e.g., 3-1) that rapidly grew in MPA contained high levels of the rearranged form of the substrate even before selection in MPA, whereas cell lines (e.g., 18-8 and BgllI-Sphl fragment containing VK21C [13] in which the SphI site had been changed to a Sall site; the 660-bp Bglll-DraI fragment spanning the bacterial gpt gene [17] in which both sites were changed to Sall sites; and the 450-bp Hindlll-Ai'all fragment containing the JK1 and JK2 segments [15] in which the HindIll site was changed to Sall and the A icall site was changed to XhoI) were cloned in the order and orientations indicated into the pDOL retroviral vector (11) , which had been linearized with BamHl and Sall; the cloning strategy destroys these BamHI and Sall sites. Because of the orientation of the V and J segments, normal joining results in the inversion of the internal gpt gene, allowing it to be expressed from the upstream LTR promoter. Diagnostic BamHI-EcoRI fragments that hybridize to a probe for the neo gene and can distinguish the unrearranged (3.5-kilobase-pair [kb]) and rearranged (2.0-kb) forms of the substrate are indicated. Map is drawn to scale between the 5' BamHI-site and the 3' XhoI site. Restriction sites: B, BamHI; Bg, BglII; E, EcoRI; S, Sall; X, XhoI. (B) Rearrangement of V-gpt-J-neo in pre-B-cell lines. Genomic DNA isolated from pre-B-cell lines containing V-gpt-J-neo was digested with BamHI and EcoRI, fractionated on 1% agarose gels, transferred to nitrocellulose, and probed with a radiolabeled neo probe. Diagnostic sized bands distinguish rearranged and unrearranged forms of the substrate. Genomic DNA was prepared either before (-) MPA reflect the inherent recombinase activity of cell lines containing the V-gpt-J-neo recombination substrate, allowing a crude quantitation of relative VDJ recombinase activity between different cell lines (summarized in Fig. 1C ). Although recombinase activity was limited to lines representing the pre-B-cell stage of B-cell development, these cell lines expressed widely differing levels of recombinase activity.
A new fluorescence-based assay for recombinase activity. As demonstrated above, stably introduced recombination substrates based on drug resistance marker genes can be used to assay for relative VDJ recombinase activity in cell lines. However, this approach is tedious (requiring long-term drug selection, Southern blot analysis, or both), does not allow for precise quantitation of recombinase activity, and cannot be used to separate cells on the basis of the presence or absence of recombinase activity. To expand the utility of this system, we have modified our conventional inversion-based recombination substrate to take advantage of a recently developed fluorescence-based assay for 3-galactosidase activity in live cells (16) . Mammalian cells expressing the bacterial 3-galactosidase gene (lacZ) can cleave the Pgalactoside analog FDG to yield fluorescein, which can be detected in viable cells by using FACS. The gpt-selectable marker gene in V-gpt-J-neo was replaced by the lacZ gene (for details, see legend to Fig. 2A) . Only inversional V-to-J joining within the introduced V-lacZ-J-neo substrate should yield cells that fluoresce after FDG substrate loading. To test the substrate and the fluorescence assay, a 'P-2 producer cell line expressing V-lacZ-J-neo was used to infect a pre-B-cell (BASC6-C2) and B-cell (W231) line with V-lacZ-J-neo. Only the pre-B-cell line containing V-lacZ-J-neo developed a subpopulation (0.65%) of fluorescing (termed lacZ+) cells (Fig. 2B and C) . To compare the V-lacZ-J-neo and V-gpt-J-neo assays, we introduced the V-lacZ-J-neo substrate into several pre-B-cell lines that had already been assayed with the V-gpt-J-neo substrate. These lines were then examined 2 to 4 weeks postinfection for levels of fluorescing cells. Notably, the relative percentage of lacZ+ cells in these cell lines correlated well with the relative recombinase activity estimated by using the V-gpt-J-neo assay (Fig. 2C) .
Use of lacZ recombination substrate to select cells with varying levels of recombinase activity. On the basis of our observation that different pre-B-cell lines rearranged introduced recombination substrates at different rates, as well as our finding that within a single cell line rearrangement of introduced constructs occurred in only a fraction of all cells, we reasoned that we could select out populations from the same cell line that displayed differing levels of recombinase activity. Taking advantage of the lacZ assay for recombinase activity, we used the FACS to subclone nonfluorescing cells from the rearranging BASC6-C2 cell line displayed in Fig.  2B . After 2 weeks in culture, these subclones were rescreened for lacZ-dependent fluorescence and were found to contain widely varying levels of lacZ+ cells compared with the parental BASC6-C2 population. For further analysis, we chose three subclones that had developed about 5-fold-fewer lacZ+ cells and two subclones that had developed about 10-fold-higher levels of lacZ+ cells compared with the parental BASC6-C2 line (compare Fig. 3A with Fig. 2B and C) . Southern blot analysis of the V-lacZ-J-neo substrate revealed that subclones with very low levels of lacZ+ cells also lacked detectable levels of the rearranged form of the substrate, whereas subclones with many lacZ+ cells displayed notable levels of the rearranged form of the substrate (Fig. 3B) . The Southern analysis was performed several weeks after the fluorogenic assay, partially explaining the imprecise correlation between percentage of lacZ+ cells and percentage of the substrate in rearranged form in the BASC4 and BASC5 subclones (but see below).
These findings demonstrated that the lacZ fluorescence assay provided a quick and efficient method for isolation of cells that rearranged their introduced V-lacZ-J-neo substrate to varying degrees. To verify that differences in the substrate from pCH110 (8) , in which both the HindIII and Dral sites were changed to Sall sites. Because of the orientation of the V and J segments, normal joining results in the inversion of the internal lacZ gene, allowing it to be expressed from the upstream LTR promoter. Diagnostic EcoRI-EcoRI and BamHI-EcoRI fragments that hybridize to a probe for the neo gene and can distinguish the unrearranged (5.8-kb) and rearranged (2.0-kb) forms of the substrate are indicated. Except for the interrupted lacZ gene, map is drawn to scale between the 5' BamHI site and the 3' XhoI site. Restriction sites: B, BamHckl; Bg, BgIII; E, EcoRI; S, Sall; X, XhoI. (B) Demonstration that only pre-B-cell lines harboring V-lacZ-J-neo develop a subpopulation of fluorescing cells. Data are presented as logarithmic histograms; x axis is scaled fluorescence per cell, and y axis indicates relative number of cells (note that scales are logarithmic). All cells were loaded with FDG as described in Materials and Methods. The parental W231 line into which the V-lacZ-J-neo substrate was introduced had a FACS plot identical to that of the population containing the substrate and is not depicted. (C) Correlation of V-lacZ-J-neo and V-gpt-J-neo recombinase assays. Percentage of lacZ+ cells, presented for the lacZ assay, was calculated by using FACS-Gal-stained V-gpt-J-neo-infected cells as negative controls and the statistical analysis regimens of FACS-DESK (16) . V-gpt-J-neo assay data are reproduced from Fig. 1C ; the cell lines are described in the legend to Fig. 1C . Fig. 2A ). A faint band between the indicated rearranged and nonrearranged bands was seen in some experiments and did not correspond to a recombinase-mediated rearrangement of the substrate. (C) Results of transient recombination substrate assays of BASC6-C2 subclones described above; BASCI was not tested. Values for recombination rates are as previously described (14), with CAMr/AMPr representing the fraction of rearranged-to-unrearranged plasmids. Experiments 1 and 2 were performed within 2 weeks of the fluorogenic assay, whereas experiments 3 and 4 were performed several months later, after freezing and thawing of the subclones. rearrangement frequency within these subclones truly reflected differences in VDJ recombinase activity and did not simply reflect differences in the particular chromosomal structure or location of the recombination substrate in individual subclones, we assayed the subclones for recombinase activity with a second assay that involved the introduction of transient recombination substrates (9) . Transient assays performed shortly after the fluoregenic assay (i.e., experiments 1 and 2, Fig. 3C ) indicated that subclones with higher lacZ-dependent fluorescence showed recombination activity higher than that of the parental line, whereas subclones with lower lacZ-dependent fluorescence displayed no detectable recombinase activity by this assay. The unstable nature of the variant recombinase phenotypes became obvious with continued propagation of these subclones, as recombinase levels assayed by the transient assay eventually randomized (experiments 3 and 4, Fig. 3C ).
Current limitations of the lacZ recombination assay. We can readily enrich for cells in which the V-lacZ-J-neo construct has rearranged and become transcriptionally activated, even from a starting cell population containing as few as 0.15% lacZ+ cells (Fig. 4) . Although we have found that unrearranged lacZ-negative cells can clearly contaminate the lacZ+ enrichment, contributing to the significant lacZ-negative cell population seen in the reanalysis, we also found that cells harboring a rearranged lacZ substrate that all initially expressed the lacZ gene (as defined by fluorescence) gradually yielded a population of nonfluorescing cells. Cells initially sorted as lacZ+ (Fig. 4A and C) rapidly developed significant lacZ-negative populations (Fig. 4B and D) . Southern blot analysis revealed that these populations contained only the rearranged form of the V-lacZ-J-neo substrate, although a significant percentage of the population (more than 50%) no longer expressed lacZ (data not shown); furthermore, individual lacZ-negative subclones generated from the lacZ-negative population also had only the rearranged form of the substrate (data not shown). This apparent decrease in expression of a rearranged lacZ gene seems related to the proposed epigenetic down regulation of long terminal repeat (LTR) promoters seen in other systems (16, 22) . Although the correlation between recombinase activities determined with the fluorogenic assay and the other two recombination assays (Fig. 2C and 3A and C) validates the utility of the fluorogenic assay for comparing relative recombinase activities between cell lines, the derivation of lacZnegative cells from lacZ+ cells currently makes it difficult to use the assay to precisely determine recombination rates in cell lines (see Discussion).
DISCUSSION
Survey of B-lineage cell lines by using stably introduced recombination substrates. The results of our survey using V-gpt-J-neo (Fig. 1C) , although more extensive than earlier studies using stable recombination substrates (4, 5, 19) , generally agree with previous findings that within the B-cell lineage, recombinase activity is limited to cell lines representing the pre-B stage. Furthermore, we were able to use V-gpt-J-neo to compare differing levels of VDJ recombinase activity among pre-B-cell lines. One potential problem with comparing recombination levels by using stably introduced substrates is that the recombination rate of a substrate within a given cell may depend on its particular chromosomal location. Our stable assays obviate this problem by examining recombination within polyclonally infected cell lines, consisting of cells harboring substrates in many different locations. The polyclonal nature of our infected cell lines, our ability to readily see substrate rearrangement before drug selection, and the correlation between the extent of this rearrangement and ability to grow in MPA-containing medium has allowed us to perform a semiquantitative comparison of VDJ recombinase activity in different pre-B-cell lines by using our stable V-gpt-J-neo substrate. Comparison of the V-gpt-J-neo assay, our novel fluorescence-based assay, and a transient substrate system on many of the same cell lines (Fig. 2C and 3A and C) confirms the utility of all the substrate systems for comparing relative recombinase activities in cell lines. The fluorescence-based assay has the additional advantages that it is rapid and easy to perform, can assay for recombination on a cell-by-cell basis in viable cells, and can be used to quickly obtain subclones with differing levels of recombinase activity. If some of the problems with LTR promoter down regulation can be overcome, the fluorescence-based assay should also allow for a much more precise and dynamic determination of recombination rates (see below).
Our comparison of recombination levels in B-lineage cell lines yielded results somewhat different from those of a similar survey using transiently introduced substrates. We were able to detect recombination in all pre-B-cell lines tested, including 70Z, which did not test positive with the transient substrates used in a previous survey (14) . This line clearly had very low VDJ recombinase activity compared with levels of all the other pre-B-cell lines that we tested, and recombination could be detected only by using the Vgpt-J-neo substrate, not V-lacZ-J-neo (Fig. 1C and 2C ). These findings indicate that the sensitivity of a stable substrate assay based on drug selection is higher than that of both our fluorescent-based assay and transient substrate assays. The previous study also found that there was generally a down regulation of recombinase activity as cells progressed through successive stages of pre-B-cell differentiation (14) . With respect to normal physiology, it is not obvious why recombination activity would decrease during pre-B-cell differentiation; in fact, on the basis of the analysis of a similar number of cell lines, we did not find such a correlation (Fig. 1C) . For example, the "pro-B" cell line BASC6-C2, which had the highest recombination activity (by at least an order of magnitude) as previously measured by the transient assay (14) , did not have a particularly high activity by either of our stable substrate assays or when we measured its recombination rate by using the same transient assay that had previously been used (Fig. 1C, 2C, and 3C) . Similarly, among lines representing later (cytoplasmic puchain positive) stages of pre-B-cell differentiation (e.g., 18-8 and 3-1), we saw wide variations in recombinase activity, with no consistent differences compared with lines representing earlier stages. Our ability to isolate subclones of the same cell line with widely differing recombinase levels suggests that different versions of the same cell line may actually contain different levels of recombinase activity, explaining some of the discrepancies between our rates and those previously obtained by using the transient assay. This possibility is also consistent with our earlier finding that levels of at least one apparent component of VDJ recombinase (terminal deoxytransferase) vary within cells of a given cell line (21) .
Our survey for recombinase activity in B-lineage cell lines allows us to compare the specificity of this activity with the expression of a series of genes specific to different stages of B-cell development. There are a large number of genes constitutively expressed in all pre-B-cell lines examined that are turned off at the pre-B-to-B-cell junction (G. D. Yancopoulos, E. M. Oltz, M. Morrow, K. Kaplan, S. Prockop, and F. W. Alt, manuscript in preparation), as appears to be the case for recombinase activity. For example, the nuclear oncogene N-myc is generally expressed in all pre-B cells but is expressed at much lower levels in 70Z (23), which we demonstrate also displays much lower recombinase activity. These associations suggest the coordinate regulation of certain genes and recombinase activity and may eventually implicate some of these genes in the regulation or expression of recombinase activity.
Potential of the lacZ recombination substrate. We have demonstrated the validity of the lacZ recombination substrate as a marker of recombinase activity. Furthermore, we have used this assay to isolate cellular subclones expressing varying levels of VDJ recombinase activity from a single recombinase-positive cell line; recombinase levels in these variants were apparently not stable after propagation in culture. On the basis of the frequency at which we obtained such variants, we presume that similar variants could have been isolated in a more laborious fashion by screening conventionally isolated subclones in transient recombination assays. However, the lacZ assay provides a much more efficient alternative for the rapid and repetitive screening and isolation of recombinase variants regardless of their frequency. Strategies based on such an assay would be much more practical than previously described assays for the isolation of cells stably expressing very low or very high levels of VDJ recombinase activity. Stable recombinasenegative variants could theoretically be isolated by repetitively sorting and screening for unrearranged subclones of one of the unstable recombinase-negative variants. V-lacZ-J-neo contains replication origins that allow for the transient replication of the substrate in mammalian cells ( Fig. 1; 11) ; strategies designed to isolate (via FACS) cells displaying high levels of recombinase could thus be performed on cells transiently transfected with many copies of the lacZ inversion substrate. These applications of the lacZ inversion substrate may prove useful in the isolation and characterization of VDJ recombinase activity as well as in the isolation of regulatory variants of VDJ recombinase activity. Furthermore, mutations within a recombinase gene(s), if isolated, could be rapidly assayed for effects on recombinase activity in stable cell lines containing but not normally rearranging the lacZ recombination substrate.
Our attempts to use the lacZ recombination assay for long-term population studies of recombinase regulation have been hindered by the gradual down regulation of the LTR promoter included in the original substrate (16, 22) . Genes driven by an immunoglobulin heavy-chain enhancer-promoter combination are expressed stably and at uniformly high levels both in pre-B-cell lines and in transgenic animals (e.g., reference 6 
